Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 Clinical Trials

10 clinical trials for Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Paclitaxel for Gastric Cancer at High Risk of Peritoneal Recurrence — RECRUITING · PHASE2
• Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer — RECRUITING · PHASE3
• Preoperative Hypofractionated Radiotherapy With FOLFOX for Esophageal or Gastroesophageal Junction Adenocarcinoma — RECRUITING · PHASE2
• Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery — SUSPENDED · PHASE2
• Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal and Gastroesophageal Adenocarcinoma — ACTIVE_NOT_RECRUITING · PHASE2
• A Prospective Study of Physical Function in Adults Who Receive Systemic Therapy for Stage I-III Gastroesophageal Cancer, FAST-GO Study — NOT_YET_RECRUITING
• Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery — ACTIVE_NOT_RECRUITING · PHASE1
• Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Individually Tailored, Supervised, Remote Exercise Intervention to Improve Physical Function for Stage I-III Gastroesophageal Cancer Survivors, PRECISE Trial — NOT_YET_RECRUITING · NA

Refine this search